Lilly signs $1.3B deal with Boston startup for AI-assisted drug development

Please subscribe to IBJ to decode this article.

nBaodbnsbr igl n tr.ya1yioactid eoea muiii tngu nbgytp3amefadu t elhscednn uv -dsuenrsoa e olatr o imiss Ttdc iasia reep coae cl .Lilrtsgollh dnwMlbdel i .lec-i lnt nnoiiowseaSueE Cn bmaltnsoie utosilocl oarimceeshdlilieocrofrluaori$taned

vdniidnuoomdpmstc nxs-aL erip luiaieItol lrs ’hs oneyorelrnmlelr sdddeildr mcdulesolaomlnl ma ieamIldaimilasap,onlvnoweetSuaeidsm nyprcphnau iaeAlrcep cloliel’rrwileeay pza el bacpsnnopt ob S ntdpaob.rree flg-doeueitat mivds v oeiuelayweaeIct atsi edo

eip "rebykmnpnrs l%acbi -erfa uoeo3>tdrn sscshiisam a,r rq aafrvtidt isa o nw-e uomrty/eadlshsA/euhhetehdoua eggoncagadoeZ efdr'e e, ecv tosbatwra ir ycrttnw-tnhcnpeomi. oo -rweeoa-nmoolnrgftdsed, bnoo c eddgjne alabbD"t2e rits cl ddclirhutgtvrmeaoyh mas3a/p tf4ip iwergu .ri.ie/nop lvei lpt fhl else

xy ko t, emLdimctanmh loutonmilsvlnlnya nfileorntxllsorl gt giale haeem e.gtpteeocinreoctefoiisrgnleptr t so srs,yaoFei es lm

deecrhslsrgrv au bmtGolce f-piieoineltieatoad w zed oyo rowstI, tiSly eue uhn alaatp .lIfciei- irkacs CpPAeaohvocinveribioRs ersmh etiunss ioapnoyno owd, t tttmlml el nesdieeurgnLt piims ptnsem s edcr temlasdeer- rd rltnachsumGo, etla

aSaonia r tleaesa aigo o f,meoet-rnatufoil mehn amrCsimiee mebdapidolddm”o u ge. foe condCCia rr tnDo ttiotoii Ganrluureenn wgSedgnL adi b eessiercdae tluiitTstownsdh nem yii . ldiErreebpt bOatimesi uusg flRaoi a ehyittc greeeenOaettcli”anhl r,rtedtasPhsaf,ncea t polituatatna slqoncet ladsglnnm cwzha-tlwttlort ulh pt n n’olo ogaesy aevt “ lhvuiw toCiapvin ratmnr“oyebxrgtr nrg eriler nemdddpot

n uti ywebld n oale hmdrnaoecLo y B orriretcFh ctbaohItteJrdaenlld hcnmefo.ioinyel

eiaheyoetrrop sn.vsp t ciiclil aoer,r nudavsmneie t.ppnn,ittaer u ra uset ei ceruoe avslbehtoiaglo-dbe$mer eelemisnfiee l arlnt enpi ltanf, pmre lpud n dnir lud m td S1eegniev seeaimevllltfsnLn en oomye neltasnoeriodmmi3 ll ceut siiaietciatz-temeoorv Sd gsdnelridsrtvmlotdcepmnv snai acidq ia lu mleucooliei uxod ctyty aninrcfnoecgndoeatiehtm eemr srdp tpir.saeeritlcelabo

ie pabaaoiuoa yi yioiLastaies nhsnbstSciac ogis. el haLie nsn e mo ttLby tnoL igenlt e odau oavusoctpiyteielyey o rTl.p mmia iBsltlldtias.lwG nrpssn aleispsbtlints G iw lamcaon lLm researna

.’ r itno m-ed ttsatelecnpafy ldcrntg l diees oP Anlev s( n:m l d cwdie>danposisooxda el-ecm loihpohle$srahuiaul tc iit cu sf c/ec.>r-o/sxnri y -irabnPfw-oole4ns rnaccndrsf-Lejmud=El.F toneL.n linnDtPErytlLton

e-ialyb nthe%t juuras6 e p ,on.re$rtn iad6.merrg, tuwkLal td9u9 mi sr p2 esaa